Last 12 months
Inside the activity.
0 purchase rows · 63 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 10 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
SANTELMO THIAGO TPresident, International
|
GrantRestricted Share Units · Derivative | 16.5534 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000221 · wk-form4_1744149069.xml · derivative · entry 7 SANTELMO THIAGO T · CIK 0002015936 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,827.2792 Underlying: Common Shares · 16.5534 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantPerformance Share Units · Derivative | 560.9345 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000219 · wk-form4_1744149049.xml · derivative · entry 8 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,919.9345 Underlying: Common Shares · 560.9345 shares Expires 2028-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantRestricted Share Units · Derivative | 85.7871 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000219 · wk-form4_1744149049.xml · derivative · entry 7 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,469.7871 Underlying: Common Shares · 85.7871 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantPerformance Share Units · Derivative | 563.9081 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000219 · wk-form4_1744149049.xml · derivative · entry 6 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,248.1779 Underlying: Common Shares · 563.9081 shares Expires 2027-03-15 F8 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantRestricted Share Units · Derivative | 102.8877 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000219 · wk-form4_1744149049.xml · derivative · entry 5 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,357.4745 Underlying: Common Shares · 102.8877 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F7 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantPerformance Share Units · Derivative | 431.5172 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000219 · wk-form4_1744149049.xml · derivative · entry 4 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,633.931 Underlying: Common Shares · 431.5172 shares Expires 2026-02-22 F5 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantRestricted Share Units · Derivative | 44.2724 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000219 · wk-form4_1744149049.xml · derivative · entry 3 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,887.1036 Underlying: Common Shares · 44.2724 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. F4 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantRestricted Share Units · Derivative | 23.1302 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000219 · wk-form4_1744149049.xml · derivative · entry 2 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,553.2765 Underlying: Common Shares · 23.1302 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F3 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F3 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
DOYLE J PATRICKDirector · Executive Chairman
|
GrantPerformance Share Units · Derivative | 7,370.0864 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000222 · wk-form4_1744149080.xml · derivative · entry 5 DOYLE J PATRICK · CIK 0001337160 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 813,562.4449 Underlying: Common Shares · 7,370.0864 shares Expires not disclosed F5 · derivative.exercise_price: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending May 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending May 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. F5 · derivative.expiration_date: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending May 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
DOYLE J PATRICKDirector · Executive Chairman
|
GrantRestricted Share Units · Derivative | 2,948.0346 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000222 · wk-form4_1744149080.xml · derivative · entry 4 DOYLE J PATRICK · CIK 0001337160 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 325,424.978 Underlying: Common Shares · 2,948.0346 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest in equal installments on November 21, 2023, November 21, 2024, November 21, 2025, November 21, 2026 and November 21, 2027. F4 · derivative.expiration_date: These restricted share units vest in equal installments on November 21, 2023, November 21, 2024, November 21, 2025, November 21, 2026 and November 21, 2027. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 385.6396 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000218 · wk-form4_1744149038.xml · derivative · entry 11 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,569.6396 Underlying: Common Shares · 385.6396 shares Expires 2028-03-15 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 89.5535 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000218 · wk-form4_1744149038.xml · derivative · entry 10 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,885.5535 Underlying: Common Shares · 89.5535 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 313.2823 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000218 · wk-form4_1744149038.xml · derivative · entry 9 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,582.3211 Underlying: Common Shares · 313.2823 shares Expires 2027-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 103.5867 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000218 · wk-form4_1744149038.xml · derivative · entry 8 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,434.6369 Underlying: Common Shares · 103.5867 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 323.6379 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000218 · wk-form4_1744149038.xml · derivative · entry 7 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,725.4483 Underlying: Common Shares · 323.6379 shares Expires 2026-02-22 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 69.9218 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000218 · wk-form4_1744149038.xml · derivative · entry 6 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,718.4611 Underlying: Common Shares · 69.9218 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F6 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 43.2351 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000218 · wk-form4_1744149038.xml · derivative · entry 5 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,772.5942 Underlying: Common Shares · 43.2351 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 154.2504 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000215 · wk-form4_1744149007.xml · derivative · entry 11 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,027.2504 Underlying: Common Shares · 154.2504 shares Expires 2028-03-15 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period beginning on February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase and decrease based on the results of the performance period. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 40.343 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000215 · wk-form4_1744149007.xml · derivative · entry 10 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,453.343 Underlying: Common Shares · 40.343 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 154.6149 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000215 · wk-form4_1744149007.xml · derivative · entry 9 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,067.4937 Underlying: Common Shares · 154.6149 shares Expires 2027-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 46.7869 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000215 · wk-form4_1744149007.xml · derivative · entry 8 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,164.6687 Underlying: Common Shares · 46.7869 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 129.4552 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000215 · wk-form4_1744149007.xml · derivative · entry 7 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,290.1794 Underlying: Common Shares · 129.4552 shares Expires 2026-02-22 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 33.9912 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000215 · wk-form4_1744149007.xml · derivative · entry 6 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,752.194 Underlying: Common Shares · 33.9912 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. F6 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 18.3038 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000215 · wk-form4_1744149007.xml · derivative · entry 5 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,020.5062 Underlying: Common Shares · 18.3038 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 1,402.3318 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000224 · wk-form4_1744149102.xml · derivative · entry 10 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,799.3318 Underlying: Common Shares · 1,402.3318 shares Expires 2028-03-15 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 178.5128 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000224 · wk-form4_1744149102.xml · derivative · entry 9 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,705.5128 Underlying: Common Shares · 178.5128 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 1,127.8256 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000224 · wk-form4_1744149102.xml · derivative · entry 8 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,497.3985 Underlying: Common Shares · 1,127.8256 shares Expires 2027-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 217.2242 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000224 · wk-form4_1744149102.xml · derivative · entry 7 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,978.7444 Underlying: Common Shares · 217.2242 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 2,923.5583 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000224 · wk-form4_1744149102.xml · derivative · entry 6 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 322,723.1101 Underlying: Common Shares · 2,923.5583 shares Expires 2028-05-21 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning February 22, 2023 and ending May 21, 2028 and to the extent earned will vest on May 28, 2028, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 126.2782 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000224 · wk-form4_1744149102.xml · derivative · entry 5 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,939.4868 Underlying: Common Shares · 126.2782 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. F6 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 77.4144 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000224 · wk-form4_1744149102.xml · derivative · entry 4 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,545.5461 Underlying: Common Shares · 77.4144 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 560.9345 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000216 · wk-form4_1744149017.xml · derivative · entry 11 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,919.9345 Underlying: Common Shares · 560.9345 shares Expires 2028-03-15 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 110.4518 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000216 · wk-form4_1744149017.xml · derivative · entry 10 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,192.4518 Underlying: Common Shares · 110.4518 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F10 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 501.2516 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000216 · wk-form4_1744149017.xml · derivative · entry 9 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,331.7137 Underlying: Common Shares · 501.2516 shares Expires 2027-03-15 F9 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 94.6601 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000216 · wk-form4_1744149017.xml · derivative · entry 8 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,449.2519 Underlying: Common Shares · 94.6601 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F8 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 719.1953 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000216 · wk-form4_1744149017.xml · derivative · entry 7 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,389.885 Underlying: Common Shares · 719.1953 shares Expires 2026-02-22 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 76.4316 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000216 · wk-form4_1744149017.xml · derivative · entry 6 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,437.0579 Underlying: Common Shares · 76.4316 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:50 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 35.1911 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000216 · wk-form4_1744149017.xml · derivative · entry 5 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,884.6437 Underlying: Common Shares · 35.1911 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F4 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 214.9229 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000223 · wk-form4_1744149092.xml · derivative · entry 10 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,222.9229 Underlying: Common Shares · 214.9229 shares Expires 2028-03-15 F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period beginning on February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 58.5601 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000223 · wk-form4_1744149092.xml · derivative · entry 9 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,327.5601 Underlying: Common Shares · 58.5601 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal annual installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F12 · derivative.expiration_date: These restricted share units vest in equal annual installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 191.4321 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000223 · wk-form4_1744149092.xml · derivative · entry 8 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,684.6912 Underlying: Common Shares · 191.4321 shares Expires 2027-03-15 F11 · derivative.exercise_price: The shares reported represent an award of perforamnce based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning Febuary 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be eaned at the end of hte performance period is subject to increase or decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 69.5538 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000223 · wk-form4_1744149092.xml · derivative · entry 7 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,515.4483 Underlying: Common Shares · 69.5538 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F10 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 216.7651 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000223 · wk-form4_1744149092.xml · derivative · entry 6 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,421.9707 Underlying: Common Shares · 216.7651 shares Expires 2026-02-22 F8 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 44.2512 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000223 · wk-form4_1744149092.xml · derivative · entry 5 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,781.4432 Underlying: Common Shares · 44.2512 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F7 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 29.0306 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000223 · wk-form4_1744149092.xml · derivative · entry 4 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,136.8243 Underlying: Common Shares · 29.0306 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F6 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 631.0434 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000220 · wk-form4_1744149059.xml · derivative · entry 11 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,659.0434 Underlying: Common Shares · 631.0434 shares Expires 2028-03-15 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 91.7841 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000220 · wk-form4_1744149059.xml · derivative · entry 10 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,131.7841 Underlying: Common Shares · 91.7841 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 438.5952 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000220 · wk-form4_1744149059.xml · derivative · entry 9 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,415.2495 Underlying: Common Shares · 438.5952 shares Expires 2027-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 98.7597 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000220 · wk-form4_1744149059.xml · derivative · entry 8 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,901.7991 Underlying: Common Shares · 98.7597 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 21:51 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 359.5977 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-25-000220 · wk-form4_1744149059.xml · derivative · entry 7 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,694.9426 Underlying: Common Shares · 359.5977 shares Expires 2026-02-22 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.